Home › Diffuse Large B-Cell Lymphoma › Connecticut › New Haven
Diffuse Large B-Cell Lymphoma clinical trials in New Haven, CT
8 studies for Diffuse Large B-Cell Lymphoma are looking for participants at sites in and around New Haven (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
RecruitingPhase 2
- Yale University, New Haven
- Smilow Cancer Hospital-Derby Care Center, Derby · 8 mi away
- Smilow Cancer Hospital Care Center - Guilford, Guilford · 13 mi away
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RecruitingPhase 1
- Yale University School of Medicine - Yale Cancer Center, New Haven
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
RecruitingPhase 1/2
- Yale New Haven Hospital ( Site 1012), New Haven
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
RecruitingPhase 1
- Yale University, New Haven
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
RecruitingObservational study
- Yale University, New Haven
DALY II USA/ MB-CART2019.1 for DLBCL
RecruitingPhase 2
- Yale University, New Haven
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RecruitingPhase 1
- Yale Cancer Center, New Haven
Hyperfractionated Dual Equivalent Fractionated Radiation Therapy
Recruiting
- Yale University, New Haven
Diffuse Large B-Cell Lymphoma trials in other cities
- New York City, NY21 studies
- Baldwin Park, CA19 studies
- Chicago, IL18 studies
- Houston, TX17 studies
- Los Angeles, CA17 studies
- Milwaukee, WI16 studies
- Boston, MA16 studies
- Philadelphia, PA15 studies
- Portland, OR15 studies
- Durham, NC14 studies
- Nashville, TN14 studies
- Dallas, TX13 studies
Other studies in New Haven
- Non-Small Cell Lung Cancer41 studies
- Breast Cancer37 studies
- Cancer (all types)34 studies
- Metastatic Cancer23 studies
- Lung Cancer23 studies
- Head and Neck Squamous Cell Carcinoma22 studies
- Colorectal Cancer21 studies
- Prostate Cancer21 studies
- Ovarian Cancer21 studies
- Acute Myeloid Leukemia19 studies
- Opioid Overdose17 studies
- Alcohol Use Disorder (AUD)17 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.